COMMONWEALTH CANCER CONSORTIUM INC (EIN 851681659) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2020

Legal Domicile

Principal Officer

WILLIAM HULME

Phone

8007579881

Tax Period

2024-01-01 to 2024-12-31

COMMONWEALTH CANCER CONSORTIUM INC, founded in 2020, is a mid-sized nonprofit that reported $13.4M in total revenue in fiscal year 2024. Revenue surged 462% from the prior year, signaling strong growth momentum. Expenses of $28.7M exceeded revenue, resulting in a 114% operating deficit.

Mission

BREAK THROUGH CANCER IS A FOUNDATION DEDICATED TO SUPPORTING TRANSLATIONAL RESEARCH IN THE MOST DIFFICULT TO TREAT CANCERS. OUR PARTNER ORGANIZATIONS ARE AMONG THE TOP CANCER RESEARCH CENTERS AND TOGETHER, REPRESENT SOME OF THE MOST BRILLIANT, CREATIVE MINDS IN THE COUNTRY. WE BELIEVE BREAK THROUGH CANCER IS THE BEGINNING OF A SCIENTIFIC MOVEMENT THAT ACCEPTS NOTHING LESS THAN MULTI-INSTITUTIONAL COLLABORATION IN PATIENT CENTRIC CANCER RESEARCH. THE FOUNDATION WILL WORK CLOSELY WITH TEAMS OF SCIENTISTS, ENGINEERS, AND CLINICAL RESEARCHERS TO FOCUS ON DIAGNOSING, TREATING, AND IDEALLY CURING SOME OF THE MOST INTRACTABLE FORMS OF CANCER. WHILE MANY PATIENTS HAVE BENEFITED FROM ADVANCES IN RESEARCH AND TECHNOLOGY, THERE ARE FAR TOO MANY WHO HAVE BEEN LEFT BEHIND. THERE ARE TOO MANY CANCERS WHERE THE NEEDLE REMAINS UNMOVED. BREAK THROUGH CANCER IS COMMITTED TO MAKING HEADWAY IN THESE EXTREMELY COMPLEX, CHALLENGING DISEASES, AND COMMITTED TO FINDING HOPE FOR PATIENTS AND THEIR FAMILIES.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2024)

Revenue Breakdown

Contributions & Grants $13,402,699

Program Service Revenue $0

Investment Income $6,986

Other Revenue $0

TOTAL REVENUE $13,409,685

Expense Breakdown

Grants Paid $0

Salaries & Benefits $3,339,414

Fundraising Expenses $0

Program Expenses $26,250,079

Other Expenses $25,398,843

TOTAL EXPENSES $28,738,257

Year-over-Year Comparison

	2024	2023	Change
Revenue	$13,409,685	$2,386,142	+4.6%
Expenses	$28,738,257	$32,184,501	-0.1%
Net Income	$-15,328,572	$-29,798,359	-0.5%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

Volunteers

N/A

Governance Policies

✓ Conflict of Interest Policy

✓ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

⚠ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

$807,091

Total Directors

$262,500

Key Employees

$1,134,557

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
BILL GOODWIN	DIRECTOR	1.00	Director	$0	$0	$0
ALICE GOODWIN	DIRECTOR	1.00	Director	$0	$0	$0
JOHN SHERMAN	DIRECTOR	1.00	Director	$0	$0	$0
SUSAN HOCKFIELD	DIRECTOR	1.00	Director	$0	$0	$0
GIULIO DRAETTA	DIRECTOR	1.00	Director	$0	$0	$0
DAVID JAFFRAY	DIRECTOR	1.00	Director	$0	$0	$0
BILL NELSON	CHAIRMAN	1.00	Director	$0	$0	$0
DAVID SCHEINBERG	DIRECTOR	1.00	Director	$0	$0	$0
MATT VANDER HEIDEN	DIRECTOR	1.00	Director	$0	$0	$0
LISA DEANGELIS	DIRECTOR	1.00	Director	$0	$0	$0
BENJAMIN EBERT	DIRECTOR	1.00	Director	$0	$0	$0
BILL HAHN	DIRECTOR	1.00	Director	$0	$0	$0
ELIZABETH JAFFEE	DIRECTOR	1.00	Director	$0	$0	$0
TYLER JACKS	PRESIDENT/DIRECTOR	20.00	Officer Director	$250,000	$12,500	$262,500
LISA SCHWARZ	COO/CPO/SECRETARY	40.00	Officer	$268,629	$51,135	$319,764
WILLIAM HULME	CFO/TREASURER	40.00	Officer	$213,080	$11,747	$224,827
JESSE BOEHM	CHIEF SCIENCE OFFICER	32.00	Key Emp	$254,285	$49,229	$303,514
KARI MCHUGH	CHIEF COMMUNICATIONS OFFICER	40.00	Key Emp	$211,962	$33,118	$245,080
MICHEAL NOBLE	CHIEF DATA SCIENCE OFFICER	40.00	Key Emp	$303,386	$42,838	$346,224
TERENCE MCGOWAN	MANAGING DIRECTOR OF DEVELOPMENT	40.00	Key Emp	$224,788	$14,951	$239,739
CHRISTINA SCHULTZ	SR. DIRECTOR OF SCIENCE PROGRAMS	40.00	Highest	$202,116	$13,880	$215,996
JONATHAN GRABENSTATTER	DIRECTOR, STRATEGIC ALLIANCES	40.00	Highest	$175,692	$36,637	$212,329
HENRY DEWHURST	PRINCIPAL DATA SCIENCE ENGINEER	40.00	Highest	$141,569	$43,593	$185,162
LUCIAN DE WAAL	SCENTIFIC PORTFOLIO MANAGER	40.00	Highest	$132,975	$33,712	$166,687
JOHN OKELLO	SCENTIFIC PORTFOLIO MANAGER	40.00	Highest	$124,081	$30,514	$154,595

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	$13,409,685	$28,738,257	$57,023,112	$-15,328,572
2023	$2,386,142	$32,184,501	$73,203,359	$-29,798,359
2022	$27,161,244	$24,291,674	$102,328,231	$2,869,570
2021	$99,715,148	$1,511,418	$98,272,406	$98,203,730
2020	$267,646	$267,646	No data	No data

COMMONWEALTH CANCER CONSORTIUM INC